Granulin Mutation
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Study to Assess the Safety, Tolerability, and Pharmacodynamic (PD) Effects of FRM-0334 in Subjects With Prodromal to Moderate Frontotemporal Dementia With Granulin Mutation (NCT02149160) | FORUM Pharmaceuticals Inc | 2014-10-01 |
Track Granulin Mutation automatically
Every clearance here is in the API, with alerts when new ones post.